Happy Sunday investors and traders ! We wanted to

New Post Public Reply Private Reply Replies (0) Message Board

Mar 16, 2014 at 12:33 PM

Happy Sunday investors and traders ! We wanted to take the time when the market was closed to discuss the following three stocks, HHSE NTEK and MFST. Our due diligence has uncovered some pretty amazing things going on between NTEK and HHSE and between NTEK and MFST. We have alerted all three companies here on FISP and we own these three and continue adding more shares on all three. The reason why is simple, they all make $$$ and all are increasing their revenues by coming together and doing joint ventures with each other which then adds to their bottom lines. We love the CEOs at each company too. All very savvy men with solid business skills that have led their companies to profitability and increased cash flows. Let us take some time below to discuss each company and the due diligence we have compiled on each hot company to own. We also believe that each stock is VERY undervalued at their current PPS and that will soon change as more and more folks find out about each company. The supply of shares in the market will dwindle while demand for the shares in these companies soars with their increasing revenues, profits and business developments. We are buyers of all three of these stocks based on our due diligence of these companies. We are not financial advisors so be sure to do your own due diligence of the companies and do not buy these companies based on our due diligence alone. Do your homework and you will see why we are buying these three stocks.

HHSE

Hannover House became a publicly traded company in late 2009 when it reverse merged into the TDGI shell and subsequently went through a name and symbol change to HHSE. The stock went from 0.0015 to as high as 6.6 cents and was in a blue sky breakout but unfortunately the previous shell owner sold into that run with shares he should never have had. That unfortunate event is the only reason the stock is not well above 15-25 cents. The company in the meantime went through some growing pains and learned from a few business mistakes and has now become a very smart and savvy company with stronger margins and a business plan that is developing into one that will see the company at much much higher PPS prices. The company management gets it. They have an investors blog they use regularly to communicate with the investment community. They are very protective of their share structure. They reduce the share structure over time as they can with share retirements and the management conducts their business and investor relations as if it were a fully transparent Nadsaq company with annual shareholder meetings in person with management, the investor blog, disclosure statements and now 8K filings. The company is voluntarily submitting 8Ks, 10Qs to SEC Edgar system and will soon have their Form 10 and 2 years of audited financials approved for the move to OTCQB, expected any time now. Eric Parkinson who was the CEO of Hemdale (a Nasdaq Company) knows the entertainment business better than most. He is very connected to Hollywood and all the major motion picture companies and has strong business relationships with all major retailers including Walmart, Bet Buy, Amazon, etc. The company jointly announced that they will be launching VODwiz which is a joint venture between HHSE and NTEK to provide the general public video on demand service for thousands of independent titles. This internet streaming service is another choice like Netflix or Hulu but brings thousands of titles not available through these other content providers. We love the HHSE potential as both a company and a VERY undervalued stock. We are buyers of the stock indefinitely. From a charting perspective, the stock has a golden cross forming on the daily chart and it looks as though that powerful technical event will take place in the very near future. See Daily chart below.

NTEK

Nanotech Entertainment (OTC: NTEK) is the HOTTEST Tech stock on the OTC by far. The company is making money hand over fist. They are projected to do $33M in revenues for 2014. They have announced quarterly dividends that will increase to shareholders as profits continue to grow. The company has developed the Nuvola NP-1. This product is the world's first streaming media player that supports 4K Ultra HD Movies. It has the fastest mobile processor on the market today and is set up with major wholesale distributors and major retailers to be announced in the near future. The company through its JV with HHSE is also partners in their own video on demand service for thousands of independent titles leveraging Hannover House's expertise in the movie industry which will mean increased profits for the company. The company has joint ventures and businss with partners such as MFST who is going to have its own ROKU channel under the NTEK umbrells for a health channel again adding revenue and profit to NTEK. NTEK is a monster high tech company that is definitely NASDAQ BX bound once it stays on the OTCQB for a specified time frame starting this summer when its audited financials and Form 10 are approved by the SEC. We love the stock and we have been using the recent pullback to buy up a ton of shares and continue to add to this winner. Dividends start paying in April. CEO is top notch. No brainer investment for one's portfolio as a tech stock. From the look of the daily chart below, we have nice bounce in procees with money flowing in, accumulation going up, MACD crosses and TRIX about to cross up. RSI has plenty of room to run too. We love the technicals on the daily NTEK chart!

MFST

Medifirst Solutions (OTCQB: MFST) is an SEC reporting medical company that is currently doing busness in New Jersey/New York area and in their new medical center in Boca Raton, Florida. Medifirst Solutions has established practice services and protocols to generate new revenues by establishing a specialized "medical services" within the practice. Medical, healthcare and wellness services and products are designed to help patients achieve better outcomes in their overall health and well-being. Using cutting-edge and innovative technology, we have created exciting new healthcare and medical services and products for the healthcare and mental health industry. They are dedicated to provide innovative drug free and pain free treatments, services and products for people to make better and healthier choices and improve their quality of life. Additionally, MFST management has decided to enter the Medical Marijuana industry with the State of Florida approving MJ as a medical treatment and several other states where Medifirst Solutions will leverage their medical expertise. They have a medical doctor on staff, Dr. Rubin is a licensed medical doctor in several states. MFST has a very solid joint venture with NTEK for a roku channel that will be used for their products and shows designed by Medifirst staff to introduce these cutting edge technologies and will publish many Medical MJ shows nationally as well. We are buyers of this stock. We love the share stucture which is only 10.2M shares in its float and 15M shares in its OS. The CEO is very respected in the industry and is very protective of its share structure and his shareholders. The sky is the limit for this company and we expect a strong move up in share price as the company gets discovered by the investment community. At this point the stock is still very much a hidden gem but that will not last much longer as marketing kicks in nationally though trade shows, TV, radio, magazines, social media and PR/IR campaigns continue positively.

Medifirst Solutions Inc. (MFST) Stock Research Links

MFST Board Company Profile Buy Rating Time & Sales News Filings Financials

My Favorite plays are on the Nasdaq DIP and RIP Board http://investorshangout.com/NASDAQ-DIP-and-RIP-87909/
My Favorite Paid chat room with amazing chart setups is The Trading Stock Lounge http://www.thetradingstocklounge.com/

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hilarity and Hassles in NYC Co-op Life Exposed in New Book

Co-op Living: Not All It's Cracked Up to Be Let me tell you something, buying a co-op in New York City isn't just signing on the dotted line and moving in. Nope, it's a whole damn production. Jeff Namian's book, Thin Walls/Thick Ears, lays it all out with a mix of humor and hard truths, painting a stark picture of NYC co-op living. He's not just telling his own story of...

Hot Property Alert: Prime Storage Facility Sale in Texas

Investment Gold in Abilene's Storage Sector Diving headfirst into the world of bricks and mortar, the opportunity brewing over in Abilene, Texas, packs a potent punch for anyone keen on beefing up their real estate portfolio with a top-notch asset. We're talking about Spare Feet Self Storage, a slick, Class A self-storage facility, serving the cream of the crop in a...

Palm Beach Royals Boost Pickleball's Popularity Surge

A New Era for Pickleball in Palm Beach It might be time to re-evaluate pickleball if you weren't paying attention before. The Palm Beach Royals have wrapped up their first Major League Pickleball season with a bang, marking a pivotal year for the sport. This underdog tale of graft and grit is carving out a new chapter in the world of sport. Record-Breaking Season for MLP...

ProClad Unveils Innovative Hybrid 2.0 Cookware

Revolutionizing Cookware: The Launch of Hybrid 2.0 Today, everyone's buzzing about ProClad's big reveal—the Hybrid 2.0 Pan. Now, before you roll those skeptical eyes, hear me out. This isn’t your average bit of kitchen fluff; it’s a heavyweight contender stepping into the everyday cooking ring. What they've done here is combine the muscle of stainless steel searing...

Dan Brown Joins Guidewire: Big Moves in P&C Software

Turning the Insurance World on Its Head Just when you think the enterprise software scene is getting predictable, along comes a bit of news to shake things up. Guidewire, a name known in the P&C insurance software world, has roped in a veteran—Dan Brown—who's got more than a quarter-century under his belt shaping product strategies. It’s not just another suit...

China Automotive Systems Hits Milestone with ASPICE 4.0 CL2

An Automotive Feat in R&D Now here's a story that should make waves across the automotive sector. China Automotive Systems, Inc. (NASDAQ: CAAS), a titan of power steering development in China, has nailed it by meeting the ASPICE 4.0 Capability Level 2. That's a big one, folks. Verified by a partnership between a European automaker and UL, this achievement is no fluke....

Christmas Injury Lawyers Unveils SC Knowledge Center

In the world of legal labyrinths, sometimes you just need a guiding light, especially following a car accident. That's where the freshly launched South Carolina Car Accident Law Knowledge Center steps in. It’s no magic wand, but Christmas Injury Lawyers are certainly trying to cut the chaos. This online hub covers more ground than a small library, boasting 40 guides...

Travelers Turn to Direct Booking Amid Cost Surge

Getting Ahead of the Travel Expense Game Rising fees and tighter budgets haven't persuaded holiday travelers to abandon their plans. Instead, they’re sharpening their axes, looking for clearer paths to their vacation goals without slicing off an arm and a leg. With the cost of travel climbing faster than a runaway elevator, folks are getting smart about where their...

Event Industry Power 50 Voting Surge Ahead of Close

An Unexpected Wave of Enthusiasm in Event Industry The Event Industry Power 50 is getting some serious action this year. Over 3,500 votes have already rolled in, smashing last year's numbers with days still left on the clock. It seems like folks can't wait to see their favorite event powerhouses crowned at this year's gala, which kicks off October 27 in New York City....

OMLYCLO Shakes Up U.S. Biologic Market as Key Player

Ah, the pharmaceutical game is shifting again, and this time Celltrion USA's putting their chips down with OMLYCLO, the shiny new omalizumab biosimilar. Here we see a product that's not just approved but interchangeable with XOLAIR, making it a front-runner in the allergic and inflammatory conditions battleground. If you're a patient or a provider navigating these murky...